# Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy

> **NCT02714049** · PHASE4 · TERMINATED · sponsor: **San Diego Sexual Medicine** · enrollment: 23 (actual)

## Conditions studied

- Hypoactive Sexual Desire Disorder

## Interventions

- **BEHAVIORAL:** sex therapy
- **DRUG:** flibanserin

## Key facts

- **NCT ID:** NCT02714049
- **Lead sponsor:** San Diego Sexual Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-25
- **Primary completion:** 2019-01-18
- **Final completion:** 2019-01-30
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Investor Initiated Grant support stopped when drug was sold.
- **Last updated:** 2022-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02714049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02714049, "Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02714049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*